Determinants of Cardiac Autonomic Neuropathy among Patients with Diabetic Peripheral Neuropathy:
A Facility-based Cross-Sectional Study
DOI:
https://doi.org/10.15605/jafes.040.02.08Keywords:
cardiac autonomic neuropathy, diabetic peripheral neuropathy, diabetes mellitus, heart rate variability, orthostatic hypotensionAbstract
Introduction. Cardiac autonomic neuropathy (CAN) is a frequently underdiagnosed consequence of diabetes mellitus (DM), increasing the risk of cardiac arrhythmia, silent myocardial ischemia, and sudden cardiac death. Diabetic peripheral neuropathy (DPN) is a common consequence of diabetes. We aimed to study the proportion of CAN among patients with DPN and identify the predictors of CAN in these patients.
Methodology. This was a hospital-based cross-sectional study conducted over a six-month period. A total of 60 DM patients with nerve conduction study–proven DPN, who fulfilled the inclusion and exclusion criteria, were enrolled in the study. CAN was assessed using both parasympathetic and sympathetic tests. A p-value of <0.05 was considered significant.
Results. The study included a total of 60 patients with diabetic peripheral neuropathy, out of whom 19 (32%) had CAN. Of the 19 patients with CAN, 11 had severe CAN. There was no statistically significant association between the severity of DPN and CAN (p = 0.162). Logistic regression analysis (Model 3) showed that when adjusted for symptoms, risk factors, hypertension, and a specific ECG finding (left atrial enlargement), the determinants of CAN were the presence of motor symptoms, being overweight or obese, and the presence of left atrial enlargement.
Conclusion. Among this cohort of persons with DM who all had DPN, CAN was found in one-third (32%) of the sample. Patients with DPN who are overweight or obese, have motor neuropathy, or have left atrial enlargement have the most significant risk for developing CAN and may be recommended for its screening. Given that CAN is a frequently overlooked condition, each early diagnosis of CAN may potentially prevent its debilitating complications and even fatal outcomes.
Downloads
References
1. Brownrigg J, de Lusignan S, McGovern A, et al. Peripheral neuropathy and the risk of cardiovascular events in type 2 diabetes mellitus. Heart. 2014;100(23):1837-43. https://pubmed.ncbi.nlm.nih.gov/25095826 https://doi.org/10.1136/heartjnl-2014-305657
2. Karthikeyan A, Manjunath PR, Latha AT, Sultana S. Prevalence of cardiac autonomic neuropathy in patients with type 2 diabetes mellitus. J Family Med Prim Care. 2023;12(9):2070-4. https://pubmed.ncbi.nlm.nih.gov/38024922 https://pmc.ncbi.nlm.nih.gov/articles/PMC10657038 https://doi.org/10.4103/jfmpc.jfmpc_609_23
3. Haq T, Ahmed T, Latif ZA, Sayeed MA, Ashrafuzzaman SM. Cardiac autonomy neuropathy in patients with type 2 diabetes mellitus having peripheral neuropathy: A cross-sectional study. Diabetes Metab Syndr. 2019;13(2):1523-8. https://pubmed.ncbi.nlm.nih.gov/31336516 https://doi.org/10.1016/j.dsx.2019.03.015
4. Röhling M, Strom A, Bönhof GJ, Roden M, Ziegler D. Cardiorespiratory fitness and cardiac autonomic function in diabetes. Curr Diab Rep. 2017;17(12):125. https://pubmed.ncbi.nlm.nih.gov/29063207 https://doi.org/10.1007/s11892-017-0959-z
5. American Diabetes Association. 2. Classification and Diagnosis of diabetes: Standards of medical care in diabetes - 2018. Diabetes Care. 2018;41(Suppl 1):S13-27. https://pubmed.ncbi.nlm.nih.gov/29222373 https://doi.org/10.2337/dc18-S002
6. Vinik AI, Ziegler D. Diabetic cardiovascular autonomic neuropathy. Circulation. 2007;115(3):387-97. https://pubmed.ncbi.nlm.nih.gov/17242296 https://doi.org/10.1161/CIRCULATIONAHA.106.634949
7. Vinik AL, Erbas T. Recognizing and treating diabetic autonomic neuropathy. Cleve Clin J Med. 2001;68(11):928-30, 932, 934-44. https://pubmed.ncbi.nlm.nih.gov/11718432 https://doi.org/10.3949/ccjm.68.11.928
8. Spallone V, Ziegler D, Freeman R, et al; Toronto Consensus Panel on Diabetic Neuropathy. Cardiovascular autonomic neuropathy in diabetes: Clinical impact, assessment, diagnosis, and management. Diabetes Metab Res Rev. 2011;27(7):639-53. https://pubmed.ncbi.nlm.nih.gov/21695768 https://doi.org/10.1002/dmrr.1239
9. Maffi P, Secchi A. The burden of diabetes: Emerging Data. Dev Ophthalmol. 2017;60:1-5. https://pubmed.ncbi.nlm.nih.gov/28427059 https://doi.org/10.1159/000459641
10. Bissinger A. Cardiac autonomic neuropathy: Why should cardiologists care about that? J Diabetes Res. 2017;2017:5374176. https://pubmed.ncbi.nlm.nih.gov/29214181 https://pmc.ncbi.nlm.nih.gov/articles/PMC5682059 https://doi.org/10.1155/2017/5374176
11. Fisher VL, Tahrani AA. Cardiac autonomic neuropathy in patients with diabetes mellitus: Current perspectives. Diabetes Metabolic Syndrome Obesity. 2017;10:419-34. https://pubmed.ncbi.nlm.nih.gov/29062239 https://pmc.ncbi.nlm.nih.gov/articles/PMC5638575 https://doi.org/10.2147/DMSO.S129797
12. Pappachan JM, Sebastian J, Bino BC, et al. Cardiac autonomic neuropathy in diabetes mellitus: Prevalence, risk factors and utility of corrected QT interval in the ECG for its diagnosis. Postgrad Med J. 2008;84(990):205-10. https://pubmed.ncbi.nlm.nih.gov/18424578 https://doi.org/10.1136/pgmj.2007.064048
13. Tannus LR, Drummond KR, Clemente EL, da Matta Mde F, Gomes MB, Brazilian Type 1 Diabetes Study Group (BrazDiab1SG). Predictors of cardiovascular autonomic neuropathy in patients with type 1 diabetes. Front Endocrinol (Lausanne). 2014;5:191. https://pubmed.ncbi.nlm.nih.gov/25505446 https://pmc.ncbi.nlm.nih.gov/articles/PMC4243695 https://doi.org/10.3389/fendo.2014.00191
14. Zoppini G, Cacciatori V, Raimondo D, et al.. Prevalence of cardiovascular autonomic neuropathy in a cohort of patients with newly diagnosed type 2 diabetes: The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS). Diabetes Care. 2015;38(8):1487-93. https://pubmed.ncbi.nlm.nih.gov/26068862 https://doi.org/10.2337/dc15-0081
15. Sacre JW, Jellis CL, Marwick TH, Coombes JS. Reliability of heart rate variability in patients with type 2 diabetes mellitus. Diabet Med. 2012;29(7):33-40. https://pubmed.ncbi.nlm.nih.gov/22172021 https://doi.org/10.1111/j.1464-5491.2011.03557.x
16. Imam MH, Karmakar CK, Khandoker AH, Jelinek HF, Palaniswami M. Heart rate independent QT variability component can detect subclinical cardiac autonomic neuropathy in diabetes. Conf Proc IEEE Eng Med Biol Soc. 2016;2016:928-931. https://pubmed.ncbi.nlm.nih.gov/28268476 https://doi.org/10.1109/EMBC.2016.7590853
17. Jacobson AF, Senior R, Cerqueira MD, et al. ADMIRE-HF Investigators Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study. J Am Coll Cardiol. 2010; 55(20):2212-21. https://pubmed.ncbi.nlm.nih.gov/20188504 https://doi.org/10.1016/j.jacc.2010.01.014
18. Hayano J, Ohashi K, Yoshida Y, et al. Increase in random component of heart rate variability coinciding with developmental and degenerative stages of life. Physiol Meas. 2018;39(5):054004. https://pubmed.ncbi.nlm.nih.gov/29693554 https://doi.org/10.1088/1361-6579/aac007
19. Vera Bril, Bruce Perkins A. Validation of the Toronto clinical scoring system for diabetic polyneuropathy. Diabetes Care. 200225(11):2048-52. https://pubmed.ncbi.nlm.nih.gov/12401755 https://doi.org/10.2337/diacare.25.11.2048
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Dr.Balachandran M, Dr. Deepsheeka G, Dr.Sadiqa Nasreen , Dr.Badrinath A K
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The full license text is available at: http://creativecommons.org/licenses/by-nc/3.0/legalcode.
To request permission to translate, reproduce, download, or use articles or images for commercial reuse or business purposes from the Journal of the ASEAN Federation of Endocrine Societies (JAFES), kindly complete the Permission Request for Use of Copyrighted Material Form and email jafes@asia.com or jafes.editor@gmail.com.
A written agreement will be issued to the requester once permission has been granted.
